Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents, Software, Services), Application (Clinical, Oncology, Forensics), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO) - Global Forecast to 2024

Report Code: BT 3161 May, 2019, by marketsandmarkets.com

[210 Pages Report] The global dPCR and qPCR market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 8.8% from 2019 to 2024. The growth of this market is primarily driven by the rising incidences of target diseases and genetic disorders; continuous technological advancements in PCR technologies, the development of miniaturized portable instruments, and incorporation of robotics; increasing investments, funds, and grants for research activities; increasing use of biomarker profiling for disease diagnostics; and the successful completion of the Human Genome Project.

Digital PCR and Real-time PCR (qPCR) Market

dPCR instruments to show the highest growth in the dPCR products market during the forecast period

The dPCR instruments segment is expected to grow at the highest CAGR in the dPCR products market. This is due to their procedural benefits (such as reduced throughput time, elimination of reference standards, absolute sample quantification, and high accuracy) over qPCR and traditional PCR instruments. This is the key factor expected to drive the overall growth of dPCR instruments during the forecast period. Other factors such as the growing demand for dPCR (particularly in forensics and drug discovery) and the rising number of dPCR-based genetic research activities across the globe are also fueling the demand-growth of dPCR instruments among end users.

By end user, hospitals and diagnostic centers hold the largest market share

The hospitals and diagnostic centers segment accounts for the largest share of the dPCR and qPCR market. Factors such as the increasing market availability of qPCR reagents in clinical diagnostic applications; ongoing expansion of healthcare infrastructure across emerging countries; high prevalence & incidence of target diseases; and growing awareness are driving the growth of this market segment.

Asia Pacific is expected to grow at the highest CAGR in the dPCR and qPCR market during the forecast period

North America is expected to account for the largest share in the global dPCR and qPCR market in 2019. However, healthcare infrastructure modernization, increasing penetration of cutting-edge diagnostic technologies (including dPCR and qPCR) for research and clinical applications, growing awareness among physicians and healthcare professionals about the benefits of gene-based disease diagnosis and treatment, and the increasing public-private support to develop novel dPCR and qPCR technologies in Asia Pacific countries have accounted for a particularly high growth rate in this region.

Digital PCR and Real-time PCR (qPCR) Market

Key Market Players

As of 2018, the dPCR and qPCR market is dominated by Thermo Fisher Scientific, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Germany), and Takara Bio, Inc. (Japan).

Other prominent players in the market include Agilent Technologies, Inc. (US), bioMιrieux S.A. (France), Fluidigm Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), Merck KGaA (Germany), Becton Dickinson and Company (US), Promega Corporation (US), Eppendorf AG (Germany), and Analytik Jena AG (Germany). An analysis of the market developments between 2016 and 2019 revealed that several growth strategies such as product launches and enhancements, partnerships, collaborations, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the dPCR and qPCR market. Product launches and acquisitions were the most widely adopted growth strategies by market players.

F. Hoffmann-La Roche (Switzerland) is a pioneer in the field of life science and biotechnology-based research products and one of the leading market players in the diagnostics industry. The company’s Diagnostics business division operates in the dPCR and qPCR market. The company has a diverse molecular diagnostics product portfolio and a strong geographic presence in more than 100 countries across the world.

Roche focuses mainly on product development and commercialization to strengthen its position in the dPCR and qPCR market. The company has launched several products and secured marketing approvals from various authorities during 2016–2019, including the cobas plasma separation card (2018), cobas HPV assay kit (2017), cobas MRSA/SA nucleic acid test kit in European countries (2017), and cobas Liat PCR System (2017). Roche also focuses on partnerships to expand its market reach and improve its distribution capabilities.

Recent Developments:

  • In January 2019, QIAGEN N.V. (Germany) announced the development of next-generation systems for dPCR in the life sciences industry. It is expected to launch new products in 2020.
  • In February 2019, Bio-Rad Laboratories (US) received US FDA approval for QxDx Auto DG droplet dPCR system and the QxDx BCR-ABL %IS Kit.
  • In July 2018, QIAGEN N.V. (Germany) partnered with multiple organizations in the UK to support and establish its global genomics campus in Manchester (UK). The new Genomic Health Innovation Campus will aim at innovation in life sciences, translational sciences, and molecular diagnostics.
  • In January 2017, Bio-Rad Laboratories (US) acquired RainDance Technologies, Inc. (US), which enhanced Bio-Rad’s market position and R&D capabilities.
  • In September 2016, Danaher Corporation (US) acquired Cepheid Inc. (US) to expand its qPCR-product portfolio.

Key Questions Addressed by the Report:

  • What are the growth opportunities in this market across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of dPCR and qPCR procedures. Will this scenario continue in the next five years?
  • Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
  • What are the major application areas of dPCR and qPCR? What are the potential applications offering growth to dPCR and qPCR manufacturers?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Study Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency Used for the Study
    1.5 Market Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Market Estimation Methodology
           2.2.1 Revenue Mapping-Based Market Estimation
           2.2.2 Usage-Based Market Estimation
           2.2.3 Primary Research Validation
    2.3 Data Triangulation
    2.4 Research Assumptions
    2.5 Research Limitations

3 Executive Summary (Page No. - 32)

4 Premium Insights (Page No. - 39)
    4.1 Global dPCR and qPCR Market Overview
    4.2 qPCR and dPCR Market, By Region, 2019 Vs.2024 (USD Million)
    4.3 Global qPCR and dPCR Market Share, By Product and Service (2019)
    4.4 Global qPCR Market, By Application, 2019 vs 2024 (USD Million)
    4.5 Geographical Snapshot of dPCR and qPCR Market

5 Market Overview (Page No. - 44)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Key Market Drivers
                    5.2.1.1 Rising Incidences of Target Infectious Diseases and Genetic Disorders
                    5.2.1.2 Continuous Technological Advancements in PCR Technologies
                    5.2.1.3 Increasing Investments, Funds, and Grants
                    5.2.1.4 Increasing Use of Biomarker Profiling for Disease Diagnostics
                    5.2.1.5 Successful Completion of the Human Genome Project
           5.2.2 Key Market Restraints
                    5.2.2.1 High Device Costs Associated With dPCR
                    5.2.2.2 Technical Limitations of qPCR and dPCR Techniques
           5.2.3 Key Market Opportunities
                    5.2.3.1 Growing Market Penetration in Emerging Countries
                    5.2.3.2 Shift From Plant-Derived to Genome-Based Drug Discovery
           5.2.4 Key Market Challenges
                    5.2.4.1 Adoption and Implementation of Miqe Guidelines
           5.2.5 Key Market Trends
                    5.2.5.1 Development of Compact, Portable, and Lab-On-Chip PCR Devices
                    5.2.5.2 Ongoing Technological Integration With the PCR Process

6 dPCR and qPCR Market, By Product & Service (Page No. - 53)
    6.1 Introduction
    6.2 qPCR Products & Services
           6.2.1 qPCR Reagents and Consumables
                    6.2.1.1 Global qPCR Reagents and Consumables Market, By Application
                    6.2.1.2 Global qPCR Reagents and Consumables Market, By End User
           6.2.2 qPCR Instruments
                    6.2.2.1 Global qPCR Instruments Market, By Application
                    6.2.2.2 Global qPCR Instruments Market, By End User
           6.2.3 qPCR Software and Services
                    6.2.3.1 Global qPCR Software and Services Market, By Application
                    6.2.3.2 Global qPCR Software and Services Market, By End User
    6.3 dPCR Products & Services
           6.3.1 dPCR Instruments
                    6.3.1.1 Global dPCR Instruments Market, By Application
                    6.3.1.2 Global dPCR Instruments Market, By End User
           6.3.2 dPCR Reagents and Consumables
                    6.3.2.1 Global dPCR Reagents and Consumables Market, By Application
                    6.3.2.2 Global dPCR Reagents and Consumables Market, By End User
           6.3.3 dPCR Software and Services
                    6.3.3.1 Global dPCR Software and Services Market, By Application
                    6.3.3.2 Global dPCR Software and Services Market, By End User

7 dPCR and qPCR Market, By Application (Page No. - 71)
    7.1 Introduction
    7.2 qPCR Applications
           7.2.1 Clinical Applications
                    7.2.1.1 Infectious Disease Testing
                               7.2.1.1.1 The Wide Availability of qPCR Assays and Kits for Infectious Disease Testing is A Key Factor Driving Market Growth
                    7.2.1.2 Oncology Testing
                               7.2.1.2.1 Advent of Alternative Diagnostic Technologies for Oncology Testing to the Key Restraining Factor
                    7.2.1.3 Blood Screening
                               7.2.1.3.1 The Advantages Offered By qPCR Such as the Elimination of Post-Amplification Processing and Easy Process Automation to Drive the Demand for qPCR Products
                    7.2.1.4 Transplant Diagnostics
                               7.2.1.4.1 Increasing Commercialization of qPCR Products for Transplant Diagnostic to Drive the Market Growth
                    7.2.1.5 Other Clinical Applications
           7.2.2 Research Applications
                    7.2.2.1 Increase in Genome-Based Research Activity Boosts the Market Growth
           7.2.3 Forensic Applications
                    7.2.3.1 Limited Adoption of qPCR in Underdeveloped and Developing Countries is Expected to Restrict the Market Growth
    7.3 dPCR Applications
           7.3.1 Clinical Applications
                    7.3.1.1 Infectious Disease Testing
                               7.3.1.1.1 Accuracy and Precision of dPCR Have Made It A Prominent Tool in Infectious Disease Testing
                    7.3.1.2 Oncology Testing
                               7.3.1.2.1 dPCR Plays A Vital Role in Oncology Testing and Clinical Studies
                    7.3.1.3 Blood Screening
                               7.3.1.3.1 dPCR Offers Multiple Advantages Over Traditional Techniques for Blood Screening
                    7.3.1.4 Transplant Diagnostics
                               7.3.1.4.1 Low Market Availability of dPCR Products for Transplant Diagnostics to Reflect in Small Share of This Market Segment
                    7.3.1.5 Other Clinical Applications
           7.3.2 Research Applications
                    7.3.2.1 Wide Usage of dPCR in Genetic Research is the Primary Driver for Market Growth
           7.3.3 Forensic Applications
                    7.3.3.1 The Need to Reduce the Time and Cost of Forensic Processes is A Key Factor Driving Market Growth

8 dPCR and qPCR Market, By End User (Page No. - 90)
    8.1 Introduction
    8.2 qPCR End Users
           8.2.1 Hospitals and Diagnostic Centers
           8.2.2 Research Laboratories and Academic Institutes
           8.2.3 Pharmaceutical and Biotechnology Companies
           8.2.4 Clinical Research Organizations
           8.2.5 Forensic Laboratories
    8.3 dPCR End Users
           8.3.1 Hospitals and Diagnostic Centers
           8.3.2 Research Laboratories and Academic Institutes
           8.3.3 Pharmaceutical and Biotechnology Companies
           8.3.4 Clinical Research Organizations
           8.3.5 Forensic Laboratories

9 dPCR and qPCR Market, By Region (Page No. - 105)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 US to Dominate the North American dPCR and qPCR Market in 2019
           9.2.2 Canada
                    9.2.2.1 Government Initiatives for Supporting Genomics Research to Drive Market Growth in Canada
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Germany to Dominate the European dPCR and qPCR Market
           9.3.2 UK
                    9.3.2.1 Growing Focus on Genomics Research to Support Market Growth in the UK
           9.3.3 France
                    9.3.3.1 Initiatives for Developing Genomic Medicine to Support Market Growth in France
           9.3.4 Rest of Europe
    9.4 Asia Pacific
           9.4.1 Japan
                    9.4.1.1 Strong Research and Healthcare Infrastructure to Support Market Growth in Japan
           9.4.2 China
                    9.4.2.1 Healthcare Infrastructure Modernization to Support Market Growth in China
           9.4.3 India
                    9.4.3.1 Presence of A Large Target Patient Population to Support Market Growth in India
           9.4.4 Rest of APAC
    9.5 Latin America
           9.5.1 Brazil
                    9.5.1.1 Brazil Dominated the Latam Market in 2018
           9.5.2 Mexico
                    9.5.2.1 Favorable Trade Agreements Will Support Imports and Improve the Accessibility to dPCR and qPCR Instruments in Mexico
           9.5.3 Rest of Latin America
    9.6 Middle East and Africa
           9.6.1 Low Purchasing Power of End Users and Infrastructural Limitations to Restrain Market Growth in the Mea

10 Competitive Landscape (Page No. - 145)
     10.1 Overview
     10.2 Global Market Share Analysis
             10.2.1 Global qPCR Market Share Analysis (2018)
             10.2.2 Global dPCR Market Share Analysis (2018)
     10.3 Competitive Scenario
             10.3.1 Key Product Launches, Enhancements, and Approvals (2016–2019)
             10.3.2 Key Partnerships and Collaborations (2016–2019)
             10.3.3 Key Acquisitions (2016–2019)
             10.3.4 Key Expansions (2016–2019)
     10.4 Competitive Leadership Mapping
             10.4.1 Competitive Leadership Mapping: Major Market Players (2018)
                        10.4.1.1 Visionary Leaders
                        10.4.1.2 Innovators
                        10.4.1.3 Dynamic Differentiators
                        10.4.1.4 Emerging Companies
             10.4.2 Competitive Leadership Mapping: Emerging Companies/SMEs/Start-Ups (2018)
                        10.4.2.1 Progressive Companies
                        10.4.2.2 Starting Blocks
                        10.4.2.3 Responsive Companies
                        10.4.2.4 Dynamic Companies

11 Company Profiles (Page No. - 155)
     11.1 Abbott Laboratories
             11.1.1 Business Overview
             11.1.2 Products Offered
             11.1.3 Recent Developments (2016-2019)
     11.2 Agilent Technologies, Inc.
             11.2.1 Business Overview
             11.2.2 Products and Services Offered
             11.2.3 Recent Developments (2016-2019)
     11.3 Analytik Jena AG (A Wholly Owned Subsidiary of Endress+Hauser Ag)
             11.3.1 Business Overview
             11.3.2 Products and Services Offered
             11.3.3 Recent Developments (2016-2019)
     11.4 Becton Dickinson and Company
             11.4.1 Business Overview
             11.4.2 Products and Services Offered
             11.4.3 Recent Developments (2016-2019)
     11.5 Biomιrieux S.A.
             11.5.1 Business Overview
             11.5.2 Products and Services Offered
             11.5.3 Recent Developments (2016-2019)
     11.6 Bio-Rad Laboratories, Inc.
             11.6.1 Business Overview
             11.6.2 Products and Services Offered
             11.6.3 Recent Developments (2016-2019)
             11.6.4 MnM View
     11.7 Danaher Corporation
             11.7.1 Business Overview
             11.7.2 Products Offered
             11.7.3 Recent Developments (2016-2019)
     11.8 Eppendorf AG
             11.8.1 Business Overview
             11.8.2 Products Offered
             11.8.3 Recent Developments (2016-2019)
     11.9 F. Hoffman-La Roche Ltd.
             11.9.1 Business Overview
             11.9.2 Products and Services Offered
             11.9.3 Recent Developments (2016-2019)
     11.10 Fluidigm Corporation
             11.10.1 Business Overview
             11.10.2 Products Offered
             11.10.3 Recent Developments (2016-2019)
     11.11 Merck KGaA
             11.11.1 Business Overview
             11.11.2 Products and Services Offered
             11.11.3 Recent Developments (2016-2019)
     11.12 Promega Corporation
             11.12.1 Business Overview
             11.12.2 Products and Services Offered
             11.12.3 Recent Developments (2016-2019)
     11.13 Qiagen N.V.
             11.13.1 Business Overview
             11.13.2 Products Offered
             11.13.3 Recent Developments (2016-2019)
     11.14 Takara Bio, Inc.
             11.14.1 Business Overview
             11.14.2 Products and Services Offered
             11.14.3 Recent Developments (2016-2019)
     11.15 Thermo Fisher Scientific, Inc.
             11.15.1 Business Overview
             11.15.2 Products and Services Offered
             11.15.3 Recent Developments (2016-2019)
             11.15.4 MnM View

12 Appendix (Page No. - 202)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Available Customizations
     12.4 Related Reports
     12.5 Author Details


List of Tables (120 Tables)

Table 1 Global dPCR and qPCR Market, By Technology, 2017–2024 (USD Million)
Table 2 Global qPCR Products & Services Market, By Type, 2017–2024 (USD Million)
Table 3 qPCR Products & Services Market, By Region, 2017–2024 (USD Million)
Table 4 qPCR Reagents and Consumables Market, By Region, 2017–2024 (USD Million)
Table 5 Global qPCR Reagents and Consumables Market, By Application, 2017–2024 (USD Million)
Table 6 Global qPCR Reagents and Consumables Market, By End User, 2017–2024 (USD Million)
Table 7 qPCR Instruments Market, By Region, 2017–2024 (USD Million)
Table 8 Global qPCR Instruments Market, By Application, 2017–2024 (USD Million)
Table 9 Global qPCR Instruments Market, By End User, 2017–2024 (USD Million)
Table 10 qPCR Software and Services Market, By Region, 2017–2024 (USD Million)
Table 11 Global qPCR Software and Services Market, By Application, 2017–2024 (USD Million)
Table 12 Global qPCR Software and Services Market, By End User, 2017–2024 (USD Million)
Table 13 Global dPCR Products & Services Market, By Type, 2017–2024 (USD Million)
Table 14 dPCR Products & Services Market, By Region, 2017–2024 (USD Million)
Table 15 dPCR Instruments Market, By Region, 2017–2024 (USD Million)
Table 16 Global dPCR Instruments Market, By Application, 2017–2024 (USD Million)
Table 17 Global dPCR Instruments Market, By End User, 2017–2024 (USD Million)
Table 18 dPCR Reagents and Consumables Market, By Region, 2017–2024 (USD Million)
Table 19 Global dPCR Reagents and Consumables Market, By Application, 2017–2024 (USD Million)
Table 20 Global dPCR Reagents and Consumables Market, By End User, 2017–2024 (USD Million)
Table 21 dPCR Software and Services Market, By Region, 2017–2024 (USD Million)
Table 22 Global dPCR Software and Services Market, By Application, 2017–2024 (USD Million)
Table 23 Global dPCR Software and Services Market, By End User, 2017–2024 (USD Million)
Table 24 Global qPCR Market, By Application, 2017–2024 (USD Million)
Table 25 Global qPCR Clinical Applications Market, By Type, 2017–2024 (USD Million)
Table 26 qPCR Clinical Applications Market, By Region, 2017–2024 (USD Million)
Table 27 qPCR Clinical Applications Market for Infectious Disease Testing, By Region, 2017–2024 (USD Million)
Table 28 qPCR Clinical Applications Market for Oncology Testing, By Region, 2017–2024 (USD Million)
Table 29 qPCR Clinical Applications Market for Blood Screening, By Region, 2017–2024 (USD Million)
Table 30 qPCR Clinical Applications Market for Transplant Diagnostics, By Region, 2017–2024 (USD Million)
Table 31 qPCR Market for Other Clinical Applications, By Region, 2017–2024 (USD Million)
Table 32 qPCR Research Applications Market, By Region, 2017–2024 (USD Million)
Table 33 qPCR Forensic Applications Market, By Region, 2017–2024 (USD Million)
Table 34 Global dPCR Market, By Application, 2017–2024 (USD Million)
Table 35 Global dPCR Clinical Applications Market, By Type, 2017–2024 (USD Million)
Table 36 dPCR Clinical Applications Market, By Region, 2017–2024 (USD Million)
Table 37 dPCR Clinical Applications Market for Infectious Disease Testing, By Region, 2017–2024 (USD Million)
Table 38 dPCR Clinical Applications Market for Oncology Testing, By Region, 2017–2024 (USD Million)
Table 39 dPCR Clinical Applications Market for Blood Screening, By Region, 2017–2024 (USD Million)
Table 40 dPCR Clinical Applications Market for Transplant Diagnostics, By Region, 2017–2024 (USD Million)
Table 41 dPCR Market for Other Clinical Applications, By Region, 2017–2024 (USD Million)
Table 42 dPCR Research Applications Market, By Region, 2017–2024 (USD Million)
Table 43 dPCR Forensic Applications Market, By Region, 2017–2024 (USD Million)
Table 44 Global qPCR Market, By End User, 2017–2024 (USD Million)
Table 45 qPCR Market for Hospitals and Diagnostic Centers, By Region, 2017–2024 (USD Million)
Table 46 qPCR Market for Research Laboratories and Academic Institutes, By Region, 2017–2024 (USD Million)
Table 47 qPCR Market for Pharmaceutical and Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 48 qPCR Market for Clinical Research Organizations, By Region, 2017–2024 (USD Million)
Table 49 qPCR Market for Forensic Laboratories, By Region, 2017–2024 (USD Million)
Table 50 Global dPCR Market, By End User, 2017–2024 (USD Million)
Table 51 dPCR Market for Hospitals and Diagnostic Centers, By Region, 2017–2024 (USD Million)
Table 52 dPCR Market for Research Laboratories and Academic Institutes, By Region, 2017–2024 (USD Million)
Table 53 dPCR Market for Pharmaceutical and Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 54 dPCR Market for Clinical Research Organizations, By Region, 2017–2024 (USD Million)
Table 55 dPCR Market for Forensic Laboratories, By Region, 2017–2024 (USD Million)
Table 56 dPCR and qPCR Market, By Region, 2017–2024 (USD Million)
Table 57 North America: qPCR Market, By Country, 2017–2024 (USD Million)
Table 58 North America: dPCR Market, By Country, 2017–2024 (USD Million)
Table 59 North America: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 60 North America: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 61 North America: qPCR Market, By Application, 2017–2024 (USD Million)
Table 62 North America: dPCR Market, By Application, 2017–2024 (USD Million)
Table 63 North America: qPCR Market, By End User, 2017–2024 (USD Million)
Table 64 North America: dPCR Market, By End User, 2017–2024 (USD Million)
Table 65 US: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 66 US: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 67 Canada: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 68 Canada: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 69 Europe: qPCR Market, By Country, 2017–2024 (USD Million)
Table 70 Europe: dPCR Market, By Country, 2017–2024 (USD Million)
Table 71 Europe: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 72 Europe: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 73 Europe: qPCR Market, By Application, 2017–2024 (USD Million)
Table 74 Europe: dPCR Market, By Application, 2017–2024 (USD Million)
Table 75 Europe: qPCR Market, By End User, 2017–2024 (USD Million)
Table 76 Europe: dPCR Market, By End User, 2017–2024 (USD Million)
Table 77 Germany: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 78 Germany: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 79 UK: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 80 UK: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 81 France: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 82 France: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 83 RoE: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 84 RoE: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 85 APAC: qPCR Market, By Country, 2017–2024 (USD Million)
Table 86 APAC: dPCR Market, By Country, 2017–2024 (USD Million)
Table 87 Asia Pacific: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 88 Asia Pacific: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 89 Asia Pacific: qPCR Market, By Application, 2017–2024 (USD Million)
Table 90 Asia Pacific: dPCR Market, By Application, 2017–2024 (USD Million)
Table 91 Asia Pacific: qPCR Market, By End User, 2017–2024 (USD Million)
Table 92 Asia Pacific: dPCR Market, By End User, 2017–2024 (USD Million)
Table 93 Japan: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 94 Japan: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 95 China: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 96 China: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 97 India: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 98 India: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 99 RoAPAC: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 100 RoAPAC: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 101 Latin America: qPCR Market, By Country, 2017–2024 (USD Million)
Table 102 Latin America: dPCR Market, By Country, 2017–2024 (USD Million)
Table 103 Latin America: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 104 Latin America: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 105 Latin America: qPCR Market, By Application, 2017–2024 (USD Million)
Table 106 Latin America: dPCR Market, By Application, 2017–2024 (USD Million)
Table 107 Latin America: qPCR Market, By End User, 2017–2024 (USD Million)
Table 108 Latin America: dPCR Market, By End User, 2017–2024 (USD Million)
Table 109 Brazil: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 110 Brazil: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 111 Mexico: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 112 Mexico: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 113 RoLAtam: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 114 RoLAtam: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 115 Middle East and Africa: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 116 Middle East and Africa: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 117 Middle East and Africa: qPCR Market, By Application, 2017–2024 (USD Million)
Table 118 Middle East and Africa: dPCR Market, By Application, 2017–2024 (USD Million)
Table 119 Middle East and Africa: qPCR Market, By End User, 2017–2024 (USD Million)
Table 120 Middle East and Africa: dPCR Market, By End User, 2017–2024 (USD Million)


List of Figures (43 Figures)

Figure 1 Research Design
Figure 2 Research Methodology: Hypothesis Building
Figure 3 Market Size Estimation Methodology: Global dPCR and qPCR Market
Figure 4 Data Triangulation
Figure 5 Global qPCR Products & Services Market, By Type, 2019 vs 2024
Figure 6 Global dPCR Products & Services Market, By Type, 2019 vs 2024
Figure 7 Global qPCR Market, By Application, 2019 vs 2024
Figure 8 Global dPCR Market, By Application, 2019 vs 2024
Figure 9 APAC is Expected to Grow at the Highest Rate During the Forecast Period
Figure 10 Rising Incidences of Target Infectious Diseases and Genetic Disorders is Expected to Drive Market Growth
Figure 11 North America is Expected to Dominate Both qPCR and dPCR Markets During the Forecast Period
Figure 12 Reagents and Consumables to Hold the Largest Share in the Global dPCR and qPCR Markets in 2019
Figure 13 Infectious Disease Testing to Be the Fastest Growing Application in qPCR Market During Forecast Period
Figure 14 Asia Pacific to Witness Highest Growth During the Forecast Period
Figure 15 Drivers, Restraints, Opportunities, and Challenges
Figure 16 Global Burden of HIV Infections, By Region, 2017
Figure 17 Growing Geriatric Population Across Key Geographies (2017 vs 2030)
Figure 18 Traditional PCR vs qPCR and dPCR: A Comparative Study
Figure 19 Reagents and Consumables Segment to Dominate the qPCR Products & Services Market During the Forecast Period
Figure 20 Instruments Segment to Witness the Highest Growth in the dPCR Products & Services Market During the Forecast Period
Figure 21 North America: dPCR and qPCR Market Snapshot
Figure 22 Europe: dPCR and qPCR Market Snapshot
Figure 23 Asia Pacific: dPCR and qPCR Market Snapshot
Figure 24 Latin America: dPCR and qPCR Market Snapshot
Figure 25 Key Developments By Leading Market Players in the dPCR and qPCR Market, 2016–2019
Figure 26 Global qPCR Market Share Analysis, By Key Player (2018)
Figure 27 Global dPCR Market Share Analysis, By Key Player (2016)
Figure 28 Global Competitive Leadership Mapping (Overall Market)
Figure 29 Competitive Leadership Mapping (SME/Start-UPS)
Figure 30 Abbott Laboratories: Company Snapshot (2018)
Figure 31 Agilent Technologies, Inc.: Company Snapshot (2018)
Figure 32 Endress+Hauser AG: Company Snapshot (2017)
Figure 33 Becton Dickinson and Company: Company Snapshot (2018)
Figure 34 Biomιrieux S.A.: Company Snapshot (2018)
Figure 35 Bio-Rad Laboratories, Inc.: Company Snapshot (2018)
Figure 36 Danaher Corporation: Company Snapshot (2018)
Figure 37 Eppendorf AG: Company Snapshot (2017)
Figure 38 Roche Diagnostic Division: Company Snapshot (2018)
Figure 39 Fluidigm Corporation: Company Snapshot (2018)
Figure 40 Merck KGaA: Company Snapshot (2018)
Figure 41 QIAGEN N.V.: Company Snapshot (2018)
Figure 42 Takara Bio, Inc.: Company Snapshot (2018)
Figure 43 Thermo Fisher Scientific Inc.: Company Snapshot (2018)

The study involved four major activities in estimating the current size of the digital PCR (dPCR) and real-time PCR (qPCR) market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the dPCR and qPCR market scenario through secondary research. A significant number of primary interviews were conducted from both the demand (healthcare providers, research institutes, and healthcare professionals) and supply sides (developers, manufacturers, and distributors of dPCR and qPCR products). The primaries interviewed for this study include experts from the dPCR and qPCR products industry (such as CEOs, VPs, directors, sales heads, and marketing managers of tier 1, 2, and 3 companies engaged in offering dPCR and qPCR products and services across the globe) and administrators & purchase managers of hospitals CROs, research institutes, academia, and pharma and biotech companies.

The following is a breakdown of primary respondents:

Digital PCR and Real-time PCR (qPCR) Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

A detailed market estimation approach was followed to estimate and validate the size of the dPCR and qPCR market and other dependent submarkets, as mentioned above. The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights (both quantitative and qualitative trends) on the dPCR and qPCR market. All possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size of the dPCR and qPCR industry from the market estimation approach explained above, the global market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact market value data, data triangulation and market breakdown methodology methods were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply side.

Report Objectives

  • To define, describe, and forecast the global dPCR and qPCR market on the basis of product & service, application, and end user
  • To provide detailed information on the major factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets in terms of individual growth trends, future prospects, and contributions to the overall dPCR and qPCR market
  • To analyze opportunities in the global dPCR and qPCR market for major stakeholders and detail the competitive landscape for market leaders
  • To forecast the size of market segments with respect to the five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
  • To profile key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as product developments; mergers & acquisitions; expansions; and partnerships, collaborations, & agreements

Scope of the Report

Report Metric

Details

Market Size Available for Years

2017–2024

Base Year Considered

2018

Forecast Period

2019–2024

Forecast Units

Value (USD)

Segments Covered

Product and Services, Application, End User, and Region

Geographies Covered

North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), and LATAM (Brazil, Mexico, and RoLATAM) and MEA.

Companies Covered

The major players in the market include Thermo Fisher Scientific, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMιrieux S.A. (France), Fluidigm Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), Merck KGaA (Germany), Becton Dickinson and Company (US), Promega Corporation (US), Eppendorf AG (Germany), and Analytik Jena AG (Germany).

This research report categorizes the dPCR and qPCR market based on product and service, application, end user, and region.

dPCR and qPCR Market, by Product and Service

  • qPCR Products and Services
    • qPCR Reagents and Consumables
    • qPCR Instruments
    • qPCR Software and Services
  • dPCR Products and Services
    • dPCR Instruments
    • dPCR Reagents and Consumables
    • dPCR Software and Services

dPCR and qPCR Market, by Application

  • qPCR Applications
    • Clinical Applications
      • Infectious Disease Testing
      • Oncology Testing
      • Blood Screening
      • Transplant Diagnostics
      • Other Clinical Applications
    • Research Applications
    • Forensic Applications
  • dPCR Applications
    • Clinical Applications
      • Infectious Disease Testing
      • Oncology Testing
      • Blood Screening
      • Transplant Diagnostics
      • Other Clinical Applications
    • Research Applications
    • Forensic Applications

dPCR and qPCR Market, by End User

  • qPCR End Users
    • Hospitals and Diagnostic Centers
    • Research Laboratories and Academic Institutes
    • Pharmaceutical and Biotechnology Companies
    • Clinical Research Organizations
    • Forensic Laboratories
  • dPCR End Users
    • Hospitals and Diagnostic Centers
    • Research Laboratories and Academic Institutes
    • Pharmaceutical and Biotechnology Companies
    • Clinical Research Organizations
    • Forensic Laboratories

dPCR and qPCR Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East and Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the global dPCR and qPCR market report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Report Code
BT 3161
Published ON
May, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Digital PCR (dPCR) and Real-time PCR (qPCR) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home